PricingLoginTell your story
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

genome-editing

(2)
AllCompaniesPeopleStoriesProducts
Company
Caribou Cut a Third of Its Team to Bet the Company on Two Cancer Drugs - Here’s What Focus Costs in Biotech
Health · Enterprise

Caribou Cut a Third of Its Team to Bet the Company on Two Cancer Drugs - Here’s What Focus Costs in Biotech

The CRISPR pioneer traded a sprawling platform story for two off-the-shelf cancer therapies, a smaller herd, and a very specific test: can ready-made CAR-T match custom-built medicine before the cash clock runs out?

caribou-biosciences · crisprRead →
Company
Sangamo Therapeutics, Inc.
Health · Enterprise

Sangamo Therapeutics, Inc.

Sangamo Therapeutics is a clinical-stage genomic medicine company in Brisbane, California that engineers zinc finger proteins to switch genes on, off, or rewrite them. After three decades pioneering zinc finger technology, it is racing to bring its lead gene therapy ST-920 for Fabry disease to market while building a neurology pipeline aimed at crossing the blood-brain barrier - all under the pressure of a 2026 search for strategic alternatives.

gene-therapy · genomic-medicineRead →